Last seen: Dec 16, 2025
Where do we place Bosutinib ? With regards to first line ? Second line ?
Nice points Dr Nitin. Dear residents, please ask any questions on this topic you have.
1. Low risk disease. TKI can be choosen based on discussion with the patient . no difference in OS between first gen and second gen drugs. If however...
Carrying forward the case discussion, let's say the reports for patient is pending. Let us assume that she has BCR ABL1 positive in RTPCR and no addit...
Nice article to read on CML. Happy Weekend. Will get insights tomorrow from all on management 🙏🏼 ELN-CML-2020.pdf
ELTS score sir....in TKI era it better predicts the survival ELTS-SCORE-CML.pdf
What is the current best score to assess chances of response and survival in CML?
BJH journal article on CML TLS-RISK-CLASSIFICATION-IN-CANCER.pdf
Dr. Stalin Mentor for this section Dr Stalin's opinion attached My-Opinion.pdf
Dr. Stalin Mentor for this section Dr Stalin's opinion attached My-Opinion.pdf